Literature DB >> 1845883

Two point mutations in the transmembrane domain of P68gag-ros inactive its transforming activity and cause a delay in membrane association.

S M Jong1, L H Wang.   

Abstract

The transforming protein of the avian sarcoma virus UR2 is a 68-kDa transmembrane tyrosine protein kinase. We examined the relationship between membrane localization and transforming activity of P68 by changing Val-168-Val-169 in its hydrophobic domain into Asp-168-Glu-169. The resulting transmembrane (TM) mutant (P68TM) lost transforming activity toward chicken embryo fibroblasts (CEF). We found that the mutant protein was expressed and rapidly degraded into a smaller form which was still membrane associated and kinase active. The instability of the TM mutant protein is a phenomenon only manifested in CEF, because the same mutant protein was expressed with efficiency and stability similar to those of the wild-type protein in a transient expression system in COS cells. However, there are several differences between the wild-type and the TM mutant proteins in COS cells. The wild-type protein is more heavily phosphorylated and associated with membrane fractions in a cotranslational manner. It is enzymatically active when recovered from membrane fractions. The TM mutant protein is less phosphorylated, more labile toward protease degradation, and delayed in membrane association, with a lag period of 30 min or longer, and has little kinase activity when recovered from membrane fractions. Most of the kinase-active TM mutant protein was found in the cytosol fractions. Despite the delay, most of the TM protein in COS cells was found to be membrane associated, and its orientation on the cell surface was similar to that of the wild-type protein. It is probable that loss of the CEF-transforming activity of the TM mutant protein is due to its susceptibility to protease degradation resulting from improper membrane association of the newly synthesized product. The differences in the kinetics of membrane association and the distribution of kinase activity in COS cells might not be directly applicable in explaining the inability of the TM mutant to transform CEF but are intriguing as regards protein biosynthesis and translocation. The difference between CEF and COS cells implies that different factors or pathways are involved in the biosynthesis and processing of the TM mutant protein in these two cellular environments. Changes of P68TM in the kinetics of membrane association indicate that the transmembrane domain of ros, besides functioning as a membrane anchor, also plays a role in directing initial membrane association.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845883      PMCID: PMC240503     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes.

Authors:  T Matsui; M Heidaran; T Miki; N Popescu; W La Rochelle; M Kraus; J Pierce; S Aaronson
Journal:  Science       Date:  1989-02-10       Impact factor: 47.728

2.  Amino acid sequence of bacteriorhodopsin.

Authors:  H G Khorana; G E Gerber; W C Herlihy; C P Gray; R J Anderegg; K Nihei; K Biemann
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

3.  Transmembrane domain of the AEV erb B oncogene protein is not required for partial manifestation of the transformed phenotype.

Authors:  M Bassiri; M L Privalsky
Journal:  Virology       Date:  1987-07       Impact factor: 3.616

4.  New procedure for DNA transfection with polycation and dimethyl sulfoxide.

Authors:  S Kawai; M Nishizawa
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

5.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

6.  DNA sequence of the Bryan high-titer strain of Rous sarcoma virus: extent of env deletion and possible genealogical relationship with other viral strains.

Authors:  T L Lerner; H Hanafusa
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

7.  Activation of transforming potential of the human insulin receptor gene.

Authors:  L H Wang; B Lin; S M Jong; D Dixon; L Ellis; R A Roth; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Temperature-sensitive mutants of avian erythroblastosis virus: surface expression of the erbB product correlates with transformation.

Authors:  H Beug; M J Hayman
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

9.  Molecular cloning and characterization of avian sarcoma virus UR2 and comparison of its transforming sequence with those of other avian sarcoma viruses.

Authors:  W S Neckameyer; L H Wang
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

10.  The discovery of lysosomes.

Authors:  D F Bainton
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

View more
  6 in total

1.  Modulatory effect of the transmembrane domain of the protein-tyrosine kinase encoded by oncogene ros: biological function and substrate interaction.

Authors:  C S Zong; L H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

2.  Two chimeric receptors of epidermal growth factor receptor and c-Ros that differ in their transmembrane domains have opposite effects on cell growth.

Authors:  Q Xiong; J L Chan; C S Zong; L H Wang
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 3.  Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them.

Authors:  Justin M Westerfield; Francisco N Barrera
Journal:  J Biol Chem       Date:  2019-12-25       Impact factor: 5.157

4.  Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.

Authors:  S M Jong; C S Zong; T Dorai; L H Wang
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Molecular and biochemical bases for activation of the transforming potential of the proto-oncogene c-ros.

Authors:  C S Zong; B Poon; J Chen; L H Wang
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

6.  Enhancement of transforming potential of human insulinlike growth factor 1 receptor by N-terminal truncation and fusion to avian sarcoma virus UR2 gag sequence.

Authors:  D Liu; W J Rutter; L H Wang
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.